HUP1800129A1 - A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek - Google Patents
A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületekInfo
- Publication number
- HUP1800129A1 HUP1800129A1 HUP1800129A HUP1800129A1 HU P1800129 A1 HUP1800129 A1 HU P1800129A1 HU P1800129 A HUP1800129 A HU P1800129A HU P1800129 A1 HUP1800129 A1 HU P1800129A1
- Authority
- HU
- Hungary
- Prior art keywords
- isoforms
- compounds
- selectively inhibiting
- inhibiting myosin
- myosin
- Prior art date
Links
- 102000003505 Myosin Human genes 0.000 title 1
- 108060008487 Myosin Proteins 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 title 1
- 108010029485 Protein Isoforms Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (26)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1800129A HU231285B1 (hu) | 2018-04-18 | 2018-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
| KR1020207033132A KR20210010465A (ko) | 2018-04-18 | 2019-04-18 | 미오신 2 이소형을 선택적으로 억제하는 약제학적으로 효과적인 화합물 |
| DK19779087.6T DK3781263T3 (da) | 2018-04-18 | 2019-04-18 | Farmaceutisk effektive forbindelser, der selektivt hæmmer myosin-2-isoformerne |
| PL19779087.6T PL3781263T3 (pl) | 2018-04-18 | 2019-04-18 | Farmaceutycznie skuteczne związki selektywnie hamujące izoformy miozyny 2 |
| EP19779087.6A EP3781263B1 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| US17/048,206 US11746112B2 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| AU2019256801A AU2019256801A1 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| MX2020011020A MX2020011020A (es) | 2018-04-18 | 2019-04-18 | Compuestos farmaceuticamente efectivos que inhiben selectivamente las isoformas de miosina 2. |
| MA052298A MA52298A (fr) | 2018-04-18 | 2019-04-18 | Composés pharmaceutiquement efficaces inhibant sélectivement les isoformes de myosine 2 |
| CA3097479A CA3097479A1 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| HUE19779087A HUE063424T2 (hu) | 2018-04-18 | 2019-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
| IL278105A IL278105B2 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds that selectively inhibit myosin 2 isoforms |
| FIEP19779087.6T FI3781263T3 (fi) | 2018-04-18 | 2019-04-18 | Myosiini 2 -isoformeja selektiivisesti estäviä farmaseuttisesti tehokkaita yhdisteitä |
| PCT/HU2019/050017 WO2019202346A2 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| BR112020021347-0A BR112020021347A2 (pt) | 2018-04-18 | 2019-04-18 | Compostos farmaceuticamente eficazes que inibe seletivamente as isoformas de miosina 2 |
| CN202311771677.0A CN117924285A (zh) | 2018-04-18 | 2019-04-18 | 选择性抑制肌球蛋白2同工型的药学有效化合物 |
| JP2021506072A JP7463344B2 (ja) | 2018-04-18 | 2019-04-18 | ミオシン２アイソフォームを選択的に阻害する医薬的に有効な化合物 |
| EP23184543.9A EP4276102A3 (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| CN201980040782.2A CN112334191A (zh) | 2018-04-18 | 2019-04-18 | 选择性抑制肌球蛋白2同工型的药学有效化合物 |
| SG11202010177UA SG11202010177UA (en) | 2018-04-18 | 2019-04-18 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| ES19779087T ES2963548T3 (es) | 2018-04-18 | 2019-04-18 | Compuestos farmacéuticamente eficaces que inhiben selectivamente las isoformas de miosina 2 |
| SI201930626T SI3781263T1 (sl) | 2018-04-18 | 2019-04-18 | Farmacevtsko učinkovite spojine, ki selektivno zavirajo izooblike miozina 2 |
| PT197790876T PT3781263T (pt) | 2018-04-18 | 2019-04-18 | Compostos farmaceuticamente aceitáveis que inibem seletivamente as isoformas de miosina 2 |
| PH12020551734A PH12020551734A1 (en) | 2018-04-18 | 2020-10-17 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| US18/345,772 US11845758B2 (en) | 2018-04-18 | 2023-06-30 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms |
| JP2024050808A JP2024075759A (ja) | 2018-04-18 | 2024-03-27 | ミオシン２アイソフォームを選択的に阻害する医薬的に有効な化合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1800129A HU231285B1 (hu) | 2018-04-18 | 2018-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP1800129A1 true HUP1800129A1 (hu) | 2019-10-28 |
| HU231285B1 HU231285B1 (hu) | 2022-08-28 |
Family
ID=89992670
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1800129A HU231285B1 (hu) | 2018-04-18 | 2018-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
| HUE19779087A HUE063424T2 (hu) | 2018-04-18 | 2019-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE19779087A HUE063424T2 (hu) | 2018-04-18 | 2019-04-18 | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11746112B2 (hu) |
| EP (2) | EP3781263B1 (hu) |
| JP (2) | JP7463344B2 (hu) |
| KR (1) | KR20210010465A (hu) |
| CN (2) | CN117924285A (hu) |
| AU (1) | AU2019256801A1 (hu) |
| BR (1) | BR112020021347A2 (hu) |
| CA (1) | CA3097479A1 (hu) |
| DK (1) | DK3781263T3 (hu) |
| ES (1) | ES2963548T3 (hu) |
| FI (1) | FI3781263T3 (hu) |
| HU (2) | HU231285B1 (hu) |
| IL (1) | IL278105B2 (hu) |
| MA (1) | MA52298A (hu) |
| MX (1) | MX2020011020A (hu) |
| PH (1) | PH12020551734A1 (hu) |
| PL (1) | PL3781263T3 (hu) |
| PT (1) | PT3781263T (hu) |
| SG (1) | SG11202010177UA (hu) |
| SI (1) | SI3781263T1 (hu) |
| WO (1) | WO2019202346A2 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU231285B1 (hu) | 2018-04-18 | 2022-08-28 | Printnet Kereskedelmi És Szolgáltató Kft. | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
| KR102559394B1 (ko) | 2018-06-14 | 2023-07-27 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 물질 사용 재발에 사용되는 비근육 미오신 ii 억제제 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ216519A (en) | 1985-06-13 | 1989-02-24 | Schering Corp | Polycyclic compounds and pharmaceutical compositions |
| JP2011510933A (ja) * | 2008-01-31 | 2011-04-07 | モナシュ ユニバーシティ | 血栓塞栓性障害を治療する方法 |
| WO2010120785A2 (en) | 2009-04-13 | 2010-10-21 | The Regents Of The University Of California | Methods and compositions for stem cell cultures |
| AU2011250651B2 (en) | 2010-05-05 | 2015-10-08 | Genea Ip Holdings Pty Limited | Media and methods for cell culture |
| EP2492687A1 (en) | 2011-02-23 | 2012-08-29 | Institut Gustave Roussy -Igr- | MYH10 as a new diagnostic marker of pathologies resulting from RUNX1 inactivation |
| US9492441B2 (en) | 2011-05-18 | 2016-11-15 | Michael E. DiSanto | Drug treatment of overactive bladder |
| US9994564B2 (en) * | 2011-05-18 | 2018-06-12 | Michael E. DiSanto | Myosin II ATPase inhibitor compounds |
| EP2524915A1 (en) | 2011-05-20 | 2012-11-21 | Sanofi | 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors |
| EP2777703B1 (en) * | 2013-03-15 | 2016-09-14 | Lonza Cologne GmbH | Compositions and methods for enhancing the therapeutic potential of stem cells |
| CA2937460A1 (en) * | 2014-02-18 | 2015-08-27 | Etablissement Francais Du Sang | High-resolution hla typing |
| AU2016243750B2 (en) | 2015-04-03 | 2022-02-03 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
| WO2016180918A1 (en) | 2015-05-12 | 2016-11-17 | Platod | Combination of pharmacological and microfluidic features for improved platelets production |
| US10858357B2 (en) | 2016-01-29 | 2020-12-08 | Paris Sciences Et Lettres-Quartier Latin | Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases |
| WO2019164852A1 (en) | 2018-02-20 | 2019-08-29 | Edgewise Therapeutics, Inc. | Methods and compositions for treating movement disorders |
| HU231285B1 (hu) | 2018-04-18 | 2022-08-28 | Printnet Kereskedelmi És Szolgáltató Kft. | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
| KR102559394B1 (ko) | 2018-06-14 | 2023-07-27 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 물질 사용 재발에 사용되는 비근육 미오신 ii 억제제 |
| WO2020097266A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
-
2018
- 2018-04-18 HU HU1800129A patent/HU231285B1/hu unknown
-
2019
- 2019-04-18 MX MX2020011020A patent/MX2020011020A/es unknown
- 2019-04-18 AU AU2019256801A patent/AU2019256801A1/en active Pending
- 2019-04-18 CA CA3097479A patent/CA3097479A1/en active Pending
- 2019-04-18 SI SI201930626T patent/SI3781263T1/sl unknown
- 2019-04-18 EP EP19779087.6A patent/EP3781263B1/en active Active
- 2019-04-18 BR BR112020021347-0A patent/BR112020021347A2/pt unknown
- 2019-04-18 EP EP23184543.9A patent/EP4276102A3/en active Pending
- 2019-04-18 KR KR1020207033132A patent/KR20210010465A/ko not_active Application Discontinuation
- 2019-04-18 WO PCT/HU2019/050017 patent/WO2019202346A2/en unknown
- 2019-04-18 CN CN202311771677.0A patent/CN117924285A/zh active Pending
- 2019-04-18 US US17/048,206 patent/US11746112B2/en active Active
- 2019-04-18 PT PT197790876T patent/PT3781263T/pt unknown
- 2019-04-18 MA MA052298A patent/MA52298A/fr unknown
- 2019-04-18 PL PL19779087.6T patent/PL3781263T3/pl unknown
- 2019-04-18 IL IL278105A patent/IL278105B2/en unknown
- 2019-04-18 CN CN201980040782.2A patent/CN112334191A/zh active Pending
- 2019-04-18 FI FIEP19779087.6T patent/FI3781263T3/fi active
- 2019-04-18 HU HUE19779087A patent/HUE063424T2/hu unknown
- 2019-04-18 SG SG11202010177UA patent/SG11202010177UA/en unknown
- 2019-04-18 ES ES19779087T patent/ES2963548T3/es active Active
- 2019-04-18 JP JP2021506072A patent/JP7463344B2/ja active Active
- 2019-04-18 DK DK19779087.6T patent/DK3781263T3/da active
-
2020
- 2020-10-17 PH PH12020551734A patent/PH12020551734A1/en unknown
-
2023
- 2023-06-30 US US18/345,772 patent/US11845758B2/en active Active
-
2024
- 2024-03-27 JP JP2024050808A patent/JP2024075759A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278116A (en) | Pyridazines as PAR7 inhibitors | |
| IL274540B (en) | Compounds useful for cdk7 inhibition | |
| IL277006A (en) | CD73 inhibitors | |
| IL304348A (en) | cd73 inhibitors | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| GB201819126D0 (en) | Inhibitor compounds | |
| HUP1800129A1 (hu) | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek | |
| PL3589637T3 (pl) | Związki użyteczne do hamowania ror-gamma-t | |
| SI3589638T1 (sl) | Spojine uporabne pri inhibiciji ROR-GAMMA-T | |
| GB201707114D0 (en) | Scale inhibition composition | |
| PT3710446T (pt) | Compostos úteis para inibir cdk7 | |
| GB201905370D0 (en) | Elastate inhibition | |
| GB201919095D0 (en) | Inhibitory compounds | |
| GB201917603D0 (en) | Inhibitory compounds | |
| GB201912603D0 (en) | Inhibitory compounds | |
| GB201904848D0 (en) | Inhibitory compounds | |
| GB201819136D0 (en) | Inhibitor compounds | |
| GB201806130D0 (en) | Inhibitor compounds | |
| GB201806131D0 (en) | Inhibitor compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU Free format text: FORMER OWNER(S): SONEAS KUTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU Owner name: EOETVOES LORAND TUDOMANYEGYETEM, HU Free format text: FORMER OWNER(S): SONEAS KUTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU Owner name: SONEAS KUTATO KFT., HU Free format text: FORMER OWNER(S): SONEAS KUTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU |
|
| GB9A | Succession in title |
Owner name: PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU Free format text: FORMER OWNER(S): SONEAS KUTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU; SONEAS KUTATO KFT., HU; EOETVOES LORAND TUDOMANYEGYETEM, HU Owner name: EOETVOES LORAND TUDOMANYEGYETEM, HU Free format text: FORMER OWNER(S): SONEAS KUTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU; PRINTNET KERESKEDELMI ES SZOLGALTATO KFT., HU; SONEAS KUTATO KFT., HU; EOETVOES LORAND TUDOMANYEGYETEM, HU |
|
| FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): DANUBIA SZABADALMI ES JOGI IRODA KFT., HU Representative=s name: SBGK SZABADALMI UEGYVIVOEI IRODA, HU |
|
| FH92 | Termination of representative |
Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU |